David Gaist Profile
David Gaist

@DavidGaist

Followers
40
Following
16
Media
0
Statuses
37

Professor of Clinical Neurology @UniSouthDenmark @SUND_SDU Consultant Neurologist @OUHhospital

Joined October 2022
Don't wanna be here? Send us removal request.
@ESOstroke
European Stroke Org
9 days
What an engaging way to start the European Stroke Science Workshop - with a keynote debate about IAT following MT or not and voting. We are looking forward to two days of exchange, discussions and networking. #ESSW @FishingNeurons #strokeeducation #stroketwitter
0
8
15
@JAHA_AHA
JAHA
15 days
DAPT use is associated with higher mortality after ICH compared to antiplatelet monotherapy. @ChrOvesen @DavidGaist @OUHhospital https://t.co/UDwA0RpzKV
1
8
22
@GreenJournal
Neurology Journal
9 months
This #NeurologyRF case highlights the diagnostic approach and importance of thorough clinical evaluation of young patients with intracerebral hemorrhages: https://t.co/6YXEYgwx8C
0
24
83
@mbgoeldlin
Martina Göldlin
9 months
@JAMANeuro
JAMA Neurology
9 months
Most viewed in the last 7 days from @JAMANeuro: Recurrence and features of cerebral amyloid angiopathy were associated with adjacent intracerebral hemorrhage. https://t.co/g6TGmL2xDY
0
8
15
@DavidSeiffge
David Seiffge
9 months
EURECA: New data on recurrent ICH: every second recurrence is adjacent to index ICH. Those bleedings occur early and are strongly associated with CAA. Great collaboration lead by @mbgoeldlin @StrokeBern Author interview podcast: https://t.co/wMxa6qUunG https://t.co/OYyJ91A5rO
edhub.ama-assn.org
Interview with David J. Seiffge, MD, author of Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage. Hosted by Cynthia E. Armand, MD.
3
30
46
@Ash_Shoamanesh
Ashkan Shoamanesh
10 months
Should patients with #stroke and device-detected subclinical #AFib (SCAF) receive OAC? Our subgroup analyses of the @Artesia_RCT published in @TheLancetNeuro provide novel insights indicating that they indeed should in the right setting. https://t.co/lDwfDPaSsh #CardioTwitter
2
31
65
@adrianpj1
Adrian Parry-Jones
11 months
Globally, intracerebral haemorrhage causes more loss of healthy life years than ischaemic stroke. We must prioritise ICH to reduce its burden through public health interventions, research, and improved healthcare. See our open access @WorldStrokeOrg factsheet 👇🏻
@IntJStroke
International Journal of Stroke
11 months
🌍🧠World Stroke Organization (WSO): Global intracerebral hemorrhage factsheet 2025 https://t.co/osRsPRvi0i @adrianpj1 @WorldStrokeOrg @WorldStrokeEd
0
27
51
@WorldICH
WICH
1 year
Calling all experts in #intracranial #hemorrhage! 🧠✨ Share your insights, discoveries, and research at #WICH2025. Don’t miss this chance to present among peers and contribute to advancements in the field—submit your abstract today! 📑 https://t.co/WGtsS0sJAc
0
5
5
@clauszsimonsen
Claus Z. Simonsen
1 year
Risk of Ischemic Stroke After Patent Foramen Ovale Closure | Journal of the American College of Cardiology https://t.co/SowXYCKUrA The risk of ischemic stroke after PFO closure is reduced, but remains high. 6-fold higher over 4 years!
Tweet card summary image
jacc.org
0
1
5
@IntJStroke
International Journal of Stroke
1 year
🫀Cohort study of recurrent ischemic stroke/TIA after patent foramen ovale closure 🧑‍🤝‍🧑Study of 310 patients ➡️At follow up: 8 had recurrent stroke/TIA, other adverse outcomes were uncommon 🩸🩺Recurrent stroke/TIA was more frequent in those with: hypertension, hematologic
0
6
16
@ESOstroke
European Stroke Org
1 year
ESO's #PaperOfTheMonth for September: "Recurrent Ischemic #Stroke in Patients With Atrial Fibrillation While Receiving Oral Anticoagulants," published in @JAMANeuro. 📑 https://t.co/rSjoBuwtpF #stroketwitter @HindsholmMette @Bihoey @DavidGaist @AUHdk @SyddanskUni @MGHNeurology
0
3
4
@DavidSeiffge
David Seiffge
1 year
Intriguing findings! We need to better understand what is really going on in the brain before it bleeds, beyond risk factors! Then, we might be able to treat and prevent (recurrent) ICH. That might become our EURECA one day! Well done!
@UCLStrokeRes
UCL Stroke Research
1 year
Link to Open Access paper here: https://t.co/n77Fk1OQ4U
1
13
37
@BojsenJA
Jonas Asgaard Bojsen
1 year
AI can detect stroke in MRI! Read more: https://t.co/7SfDBZVwpP #AI #stroke #MRI #neuroradiology in @InsightsImaging
0
1
7
@DavidGaist
David Gaist
1 year
We followed >8000 Danes with atrial fibrillation who had a stroke and started/restarted DOAC. For incidence rates of stroke recurrence, association of recurrence with DOAC discontinuation & more, see our article in #JAMA Neurology:
jamanetwork.com
This cohort study of patients in Denmark with atrial fibrillation investigates whether discontinuation of oral anticoagulation is associated with an increased risk of recurrent ischemic stroke.
0
12
22
@SVN_CSA
Stroke and Vascular Neurology
1 year
Left atrial appendage closure in patients with atrial fibrillation and acute ischaemic stroke despite anticoagulation @alvindasMD @guroledip https://t.co/LJzhz83FA5
0
6
17
@Ash_Shoamanesh
Ashkan Shoamanesh
1 year
"Stroke is projected to account for the largest absolute increase in healthcare costs by 2050."
@AHAScience
AHA Science
1 year
1/ For cardiovascular conditions, annual healthcare costs are projected to almost quadruple from $393 billion to $1490 billion between 2020 and 2050. Stroke is projected to account for the largest absolute increase in healthcare costs by 2050.
1
13
25
@turkbeyindamar
Türk Beyin Damar Hastalıkları Dernegi
2 years
The scientific program is now avaible of International 8th Turkish Stroke Academy and Teaching Courses https://t.co/5XXg6MN2ha #tcvds #turkishcerebrovasculardiseasessociety #Turkishstrokeacademy #8thTurkishScrokeAcademy
0
4
13
@drhougaard
Anders Hougaard
2 years
New paper out! Is triptan use associated with major ischemic events? Yes, but the risk is very low and limited to people aged 60+ with high cardiovascular risk. @ESOstroke @DavidGaist @HerlevGentofte
@JAMANeuro
JAMA Neurology
2 years
Danish population-based study of 429,612 first-time triptan users found higher relative risk of stroke (OR 3.2) and MI (OR 3.2). Absolute risk was low (only 0.003%/0.004% of users had a stroke/MI) and limited to high CVD risk profile people. https://t.co/y1J0QB81M1 #NeuroTwitter
0
8
31